[Further research of antibodies anti-"N. meningitidis" among healthy population of Bari (southern Italy) (author's transl)]
- PMID: 829400
[Further research of antibodies anti-"N. meningitidis" among healthy population of Bari (southern Italy) (author's transl)]
Abstract
Research of antibodies anti-N. meningitidis serogroups A, B, and C was carried out on 248 healthy children 7 months-10 years aged by indirect hemagglutination, to determine the age of their initial demonstration into the serum and the time of their clearness, besides the diffusion of antibodies within the infantile population. Antibodies against one or more serogroups of N. meningitidis were detected already in the second half-year life in 73 percent examined children. Frequence of antibodies is progressively increasing in the last years until to findings about 90-100%. Antibodies against N. meningitidis serogroups A were detected more frequently, and in a less degree, the ones against serogroup C. Research of antibodies after 2 and 12 months was repeated on 84 subjects; for the most part of these the antibody titre was the same.
Similar articles
-
[Application of the indirect hemagglutination test for the determination of titres of meningococcal antibodies (author's transl)].Lijec Vjesn. 1979 Aug;101(8):470-2. Lijec Vjesn. 1979. PMID: 120476 Croatian. No abstract available.
-
Serum factors and polymorphonuclear leukocytes in human host defence against Neisseria meningitidis. Studies of interactions with special reference to a chemiluminometric technique.Scand J Infect Dis Suppl. 1993;87:1-72. Scand J Infect Dis Suppl. 1993. PMID: 8511525
-
[Presence of anti-Neisseria meningitidis antibodies in the normal population of Messina].Ann Sclavo. 1977 Nov-Dec;19(6):1224-36. Ann Sclavo. 1977. PMID: 106779 Italian. No abstract available.
-
Challenges for development of meningococcal vaccines in infants and children.Expert Rev Vaccines. 2011 Mar;10(3):335-43. doi: 10.1586/erv.11.3. Expert Rev Vaccines. 2011. PMID: 21434801 Review.
-
MenACWY-TT vaccine for active immunization against invasive meningococcal disease.Expert Rev Vaccines. 2012 May;11(5):523-37. doi: 10.1586/erv.12.32. Expert Rev Vaccines. 2012. PMID: 22827239 Review.